ESPE Yearbook of Paediatric Endocrinology

Lancet Glob Health 2019;7: e492–502. DOI: 10.1016/S2214-109X(18)30563-1• The authors evaluated the effect of a Novartis programme that provides metformin at a wholesale price of US$1 per month in Kenya.• This cluster-randomized controlled trial significantly increased the availability of metformin at health facilities, but not at patient househ...

Lancet Diabetes Endocrinol 2019 Published Online March 13, 2019. DOI: 10.1016/S2213-8587(19)30083-X• Practical challenges associated with diabetes care in humanitarian contexts in low- and middle- income countries abound.• In this position paper, the authors articulate the important needs around diabetes care in the context of the 6 building blocks ...

Pediatr Diabetes. 2019;20:93–98. DOI: 10.1111/pedi.12801• The quality and availability of pediatric diabetes management varies from setting to setting depending on the available resources.• In this position paper, the authors propose a ‘levels of care’ concept with three tiers that stratifies the existing levels of care into minimal care, interm...

Diabetes Care 2018;41:1125–1131. DOI: 10.2337/dc18-er09a)• Many people currently in need of insulin are unable to access it.• Unaffordable price of insulin is a major barrier.• These authors analyse the causes of unsatisfactory access to insulin from a U.S. and global perspective.This article identifies the various ...

Lancet Diabetes Endocrinol 2019; 7: 150–60. DOI 10.1016/S2213-8587(18)30074-3• Access to blood glucose monitoring is often poor in resource-limited settings.• The authors analyse the reasons for suboptimal access, with a focus on cost, availability, system accuracy, competitive bidding, technological trends, and non-financial barriers. Urine gl...